Operating Lease, Right-of-Use Asset of Silexion Therapeutics Corp from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Silexion Therapeutics Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Silexion Therapeutics Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $442,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Silexion Therapeutics Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $442,000 +$442,000 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $472,000 +$332,000 +237% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $502,000 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $530,000 +$332,000 +168% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $0 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $140,000 30 Jun 2024 10-Q 29 Aug 2024 2024 Q2
Q4 2023 $198,000 31 Dec 2023 8-K 20 Aug 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.